RT.com
15 Jan 2022, 04:46 GMT+10
The EU's drug watchdog is warning of a ?very rare? spinal cord inflammation possibly related to AstraZeneca and J&J vaccines
The European Medicines Agency wants to put warning labels on Covid-19 jabs made by AstraZeneca and Johnson & Johnson, saying there was a ?reasonable possibility? they may have caused a spinal inflammation on rare occasions.
Following three days of meetings and discussions, the EMA's Pharmacovigilance Risk Assessment Committee (PRAC) said Friday it wants to include a warning for "very rare cases of transverse myelitis (TM) reported following vaccination" with Vaxzevria and Janssen jabs. It is also adding the condition as an "adverse reaction of unknown frequency" to the vaccine profile.
The EMA describes TM as a rare neurological condition characterized by an "inflammation of one or both sides of the spinal cord," which can cause weakness in arms or legs, tingling, numbness, pain - or loss of pain sensation - and problems with bowel and bladder function.
The recommendation comes after PRAC reviewed available information on reported cases worldwide and scientific literature, concluding that "a causal relationship between these two vaccines and transverse myelitis is at least a reasonable possibility." However, it said the "benefit-risk profile of both vaccines remains unchanged."
The warning is intended to "raise awareness among healthcare professionals and people receiving the vaccines." Doctors were told to be on alert for signs and symptoms of TM, while recipients were urged to "seek immediate medical attention" if they develop the symptoms.
Last month, EMA approved the Janssen jab as a booster for people 18 and older, to be given at least two months after previous vaccinations.
PRAC also revised the product information for AstraZeneca's Vaxzevria, to reflect that far fewer cases of thrombosis with thrombocytopenia (TTS) - blood clotting with a low platelet count - have been recorded after the second dose of the jab, compared to the first.
The use of AstraZeneca's vaccine, developed with Oxford University, has already been scaled back due to the "ultra rare" side effect, which UK government statistics last summer estimated at around 14.9 per million doses of the jab. A study published in December blamed a very specific issue with Vaxzevria's adenovirus vector.
(RT.com)
Get a daily dose of Europe Sun news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Europe Sun.
More InformationWASHINGTON, D.C.: This week, the Federal Aviation Administration (FAA) said it is taking steps to stop collisions between helicopters...
THE VATICAN - U.S. President Donald Trump met privately with Ukrainian President Volodymyr Zelenskyy in St. Peter's Basilica in Vatican...
WASHINGTON, D.C.: This week, Health Secretary Robert F. Kennedy Jr. and FDA Commissioner Marty Makary said they plan to remove artificial...
WASHINGTON, D.C.: The United States plans to press India for sweeping changes to its e-commerce policies as part of negotiations aimed...
LONDON, U.K.: British Prime Minister Keir Starmer and New Zealand Prime Minister Christopher Luxon decided to strengthen their countries'...
WASHINGTON, D.C.: The U.S. Food and Drug Administration (FDA) is stopping a quality control program that tests milk and other dairy...
SHANGHAI, China: Nissan is making a fresh push to regain its footing in China with a US$1.4 billion investment and a pledge to speed...
TOKYO, Japan: Toyota's Hino Motors and Daimler Truck's Mitsubishi Fuso are edging closer to a long-awaited merger of their truck operations,...
WASHINGTON, D.C.: The United States plans to press India for sweeping changes to its e-commerce policies as part of negotiations aimed...
BEIJING, China: China's automobile exports rose sharply in the first quarter of 2024, with 1.54 million vehicles shipped abroad, marking...
BEIJING, China: At Home Plate BBQ in Beijing, the iconic Texan brisket is about to get a new passport. The restaurant, known for its...
NEW YORK, New York - Stocks were largely higher on Friday with all the indices notching up daily and weekly gains. Steadying the markets...